ImmuPharma plc (AIM:IMM)
London · Delayed Price · Currency is GBP · Price in GBX 3.325
+0.120 (3.74%)
Sep 25, 2026, 1:42 PM GMT
ImmuPharma Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| - | - | - | - | - | 0.12 | |
Revenue Growth | - | - | - | - | - | -6.57% |
Gross Profit | - | - | - | - | - | 0.12 |
Selling, General & Admin | 1.03 | 1.09 | 1.03 | 1.02 | 0.85 | 1.01 |
Research & Development | 1.25 | 1.35 | 1.16 | 2.02 | 2.02 | 3.65 |
Other Operating Expenses | -0 | -0.01 | -0.01 | -0.12 | - | - |
Operating Expenses | 2.37 | 2.53 | 2.27 | 3.06 | 3.03 | 5.28 |
Operating Income | -2.37 | -2.53 | -2.27 | -3.06 | -3.03 | -5.16 |
Interest Expense | -2.92 | -0.01 | -0 | -0 | -0 | -0.12 |
Interest & Investment Income | - | 0.01 | 0.01 | 0 | 0 | 0 |
Currency Exchange Gain (Loss) | -0 | -0 | -0.15 | -0 | -0.02 | 0 |
Other Non Operating Income (Expenses) | 0.37 | 0.37 | 0.04 | -0.35 | -1.41 | -2.23 |
EBT Excluding Unusual Items | -4.93 | -2.17 | -2.38 | -3.42 | -4.46 | -7.51 |
Asset Writedown | - | - | -0.4 | - | - | - |
Other Unusual Items | - | - | - | - | - | -1.43 |
Pretax Income | -4.93 | -2.17 | -2.78 | -3.42 | -4.46 | -8.94 |
Income Tax Expense | -0.25 | -0.36 | -0.3 | -0.5 | -0.65 | -0.77 |
Net Income | -4.67 | -1.81 | -2.48 | -2.92 | -3.81 | -8.17 |
Net Income to Common | -4.67 | -1.81 | -2.48 | -2.92 | -3.81 | -8.17 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 530 | 491 | 416 | 362 | 303 | 251 |
Shares Outstanding (Diluted) | 530 | 491 | 416 | 362 | 303 | 251 |
Shares Change | 18.34% | 17.81% | 15.04% | 19.51% | 20.60% | 25.47% |
EPS (Basic) | -0.01 | -0.00 | -0.01 | -0.01 | -0.01 | -0.03 |
EPS (Diluted) | -0.01 | -0.00 | -0.01 | -0.01 | -0.01 | -0.03 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -1.85 | -2.37 | -1.77 | -1.36 | -2.45 | -4.88 |
Free Cash Flow Per Share | -0.00 | -0.01 | -0.00 | -0.00 | -0.01 | -0.02 |
Gross Margin | - | - | - | - | - | 100.00% |
Operating Margin | - | - | - | - | - | -4359.84% |
Profit Margin | - | - | - | - | - | -6906.55% |
Free Cash Flow Margin | - | - | - | - | - | -4126.83% |
EBITDA | -2.42 | -2.5 | -2.21 | -3.03 | -2.91 | -5.05 |
D&A For EBITDA | -0.05 | 0.04 | 0.06 | 0.04 | 0.12 | 0.11 |
EBIT | -2.37 | -2.53 | -2.27 | -3.06 | -3.03 | -5.16 |